Pinned
Why 1000 Doctors Gave This Cancer Drug A Standing Ovation? - Dr. Sandler shares how Revolution Medicines evolved from its early beginnings to becoming a leader in RAS-targeted therapies. He explains the scientific rationale behind targeting RAS-driven tumor.
